Pharma IQ Members

Industry Reports & Infographics

Pharma is devoted to providing our community with the most comprehensive selection of case studies, reports and infographics on the internet. Get in-depth information through Pharma IQ's pharma and biotechnology industry reports. Our materials aim to educate industry leaders as they make complex business decisions that drive growth, innovation and ROI. 

372 whitepaper results
of 37

This heatmap scans the cell and gene manufacturing activity occurring across Europe on the road to commercializing these therapies.Learn more


This white paper suggests an innovative R&D approach to deliver high quality products to market while reducing cost and improving ROI.Learn more

What is Pharma IQ?Pharma IQ is the leading online resource hub for the global pharmaceutical professionals who have exclusive access to a library of resources including news, trends, reports, whitepapers, videos, webinars and more. Our community of members includes over 100,000 senior level pharmaceutical professionals and decision-makers. By advertising with Pharma IQ you can reach out to your target audience through countless options and fully customisable packages by creating a sales... Learn more


This infographic explores the obstacles regularly faced by biopharmaceutical organizations, such as rising costs, repeated experiments, lack of searchability and quality assurance.Learn more


Download this troubleshooting guide to explore the important aspects to consider with compound and biosample management IT issues.Learn more

cover designing_health_facilities_for_the_future

A state-by-state look at some of Australia’s largest and most innovative health redevelopment projectsLearn more


Richard Royle, Executive Director of UnitingCare Health and Bruce Wolfe, Project Director and CEO at Conrad Gargett Riddel Ancher Mortlock Woolley, talk about the team’s strategy behind designing and building Australia’s first fully integrated digital hospital, exploring the different elements that need to be considered to design and deliver a facility which caters for new technologies.Learn more


Pharma IQ revisits the compound and biobanking markets to pinpoint any shifts or new trends in the market.Learn more


We spoke to CRISPR experts Robin Ketteler and Lorena Benedetti to find out about their work within CRISPR, insights on where the technique is heading and the field’s exciting developments.Learn more

CRISPR Content

CRISPR is now one of the most affordable forms of gene editing causing a boom in R&D over the last few years. However, the technique does have its limitations which include maintaining end to end control on genetic manipulation, avoiding off targets effects and pathway recovery post double strand break.Ahead of the 2017 CRISPR summit Javier Terriente, CSO, ZeClinics and Danilo Maddalo Lab Head ONC Pharmacology,... Learn more

372 whitepaper results
of 37